Loading Events

« All Events

BioNJ’s C-Suite Summit

October 25

Event is closed to the media.

With Insights from McKinsey & Company

Thursday, October 25, 2018, Bridgewater Marriott


Healthcare in Transformation:
Digitization, Innovation and Consumerization

The healthcare ecosystem is changing rapidly, with innovative therapies transforming standard of care, an explosion of data enabling new insights, and non-traditional players entering into the healthcare domain. Against this backdrop and evolving new research and business models, biopharma has enormous opportunity requiring it to be more agile, creative, and externally oriented than ever before. BioNJ’s C-Suite Summit brings together leaders and their teams from companies at all points along the development continuum – whether early or late stage, public or private, revenue or pre-revenue – to share insights and ideas. The sessions will focus on how biopharma can leverage this pivotal juncture and pave the way for the next generation of patient life-changing therapies.


7:00 a.m. – 8:15 a.m. Registration & Networking Breakfast Buffet

8:15 a.m. – 8:30 a.m. Welcome & Opening Remarks by Debbie Hart, President & CEO, BioNJ

8:30 a.m. – 9:15 a.m. Keynote: The Next S-Curve of Opportunity

9:15 a.m. – 10:00 a.m. Perspectives: Implications of the Transforming Ecosystem for Innovation
Industry leaders will share learnings, short- and long-term implications for innovation, marketplace dynamics and the leadership role life sciences companies will play.

10:00 a.m. – 10:30 a.m. Keynote: Addressing Affordability and Access

10:30 a.m.– 11:00 a.m. Networking Break

11:00 a.m. – 11:45 p.m.  Panel: The Empowered Patient
A panel discussion on ways that patients are becoming increasingly informed and empowered, particularly through digital channels. The panel will touch on implications for policy, data privacy, patient-centric drug development.

11:45 p.m. – 12:45 p.m. Lunch

12:45 p.m. – 1:15 p.m. Fireside Chat: John Maraganore Ph.D., CEO, Alnylam Pharmaceuticals, Chairman BIO
Interviewer: Francois Nader, Ph.D., Chair, Acceleron Pharma

1:15 p.m. – 2:00 p.m.  Panel: New Business Models
A panel discussion on new business models that are emerging and the role that “non-traditional” players are now playing in healthcare. The panel will explore how these shifts are altering the landscape of R&D, funding and sustainability, life cycle management and overall healthcare delivery, as well as presenting new opportunities for life sciences companies to forge collaborations.

2:00 p.m. – 2:15 p.m. Networking Break

2:15 p.m. – 2:45 p.m.  Fireside Chat: The Talent Gap
This session will explore an increasingly evident shortage of talent in this integrated digital age, and the implications for life sciences companies. What do industry leaders need to be doing to build the capabilities necessary to succeed in today’s dynamic environment? What strategies should be in place to cultivate, develop and retain the next generation of leaders?

2:45 p.m. – 3:15 p.m. Keynote: Industry Implications on the Regulatory Horizon

3:15 p.m. – 3:30 p.m. Closing Remarks by James Sapirstein, R.Ph., M.B.A., CEO, ContraVir Pharmaceuticals and Debbie Hart, President & CEO, BioNJ

3:30 p.m. – 4:00 p.m. Dessert Networking Reception


Save the date and join fellow executives, investors, entrepreneurs, academics and other members of the diverse and ever-evolving life sciences community for a day of learning and networking! Click here or contact Edie Esposito at EEsposito@BioNJ.org to learn about Sponsorship opportunities and place your company in the spotlight.


Thank You To Our Sponsors


October 25
Event Category:


Bridgewater Marriott
700 Commons Way
Bridgewater, NJ United States
+ Google Map